annual cash & cash equivalents:
$20.48B+$7.79B(+61.36%)Summary
- As of today (September 12, 2025), PFE annual cash & cash equivalents is $20.48 billion, with the most recent change of +$7.79 billion (+61.36%) on December 31, 2024.
- During the last 3 years, PFE annual cash & cash equivalents has fallen by -$10.59 billion (-34.09%).
- PFE annual cash & cash equivalents is now -43.31% below its all-time high of $36.12 billion, reached on December 31, 2014.
Performance
PFE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$13.25B-$4.07B(-23.49%)Summary
- As of today (September 12, 2025), PFE quarterly cash & cash equivalents is $13.25 billion, with the most recent change of -$4.07 billion (-23.49%) on June 29, 2025.
- Over the past year, PFE quarterly cash & cash equivalents has increased by +$6.15 billion (+86.61%).
- PFE quarterly cash & cash equivalents is now -74.75% below its all-time high of $52.47 billion, reached on September 27, 2009.
Performance
PFE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PFE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.4% | +86.6% |
| 3 y3 years | -34.1% | -60.2% |
| 5 y5 years | +112.3% | -41.9% |
PFE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.1% | +61.4% | -70.4% | +86.6% |
| 5 y | 5-year | -34.1% | +112.3% | -70.4% | +86.6% |
| alltime | all time | -43.3% | +5037.2% | -74.8% | +4203.0% |
PFE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $13.25B(-23.5%) |
| Mar 2025 | - | $17.32B(-15.4%) |
| Dec 2024 | $20.48B(+61.4%) | $20.48B(+105.8%) |
| Sep 2024 | - | $9.95B(+40.2%) |
| Jun 2024 | - | $7.10B(-40.5%) |
| Mar 2024 | - | $11.93B(-6.0%) |
| Dec 2023 | $12.69B(-44.2%) | $12.69B(-71.3%) |
| Sep 2023 | - | $44.18B(-1.3%) |
| Jun 2023 | - | $44.78B(+124.2%) |
| Mar 2023 | - | $19.97B(-12.1%) |
| Dec 2022 | $22.73B(-26.8%) | $22.73B(-37.1%) |
| Sep 2022 | - | $36.12B(+8.5%) |
| Jun 2022 | - | $33.30B(+39.4%) |
| Mar 2022 | - | $23.90B(-23.1%) |
| Dec 2021 | $31.07B(+154.2%) | $31.07B(+4.6%) |
| Sep 2021 | - | $29.70B(+36.8%) |
| Jun 2021 | - | $21.70B(+58.8%) |
| Mar 2021 | - | $13.67B(+11.8%) |
| Dec 2020 | $12.22B(+26.7%) | $12.22B(-44.2%) |
| Sep 2020 | - | $21.91B(-3.9%) |
| Jun 2020 | - | $22.79B(+120.2%) |
| Mar 2020 | - | $10.35B(+5.3%) |
| Dec 2019 | $9.65B(-48.8%) | $9.83B(+8.2%) |
| Sep 2019 | - | $9.09B(-29.6%) |
| Jun 2019 | - | $12.91B(+11.1%) |
| Mar 2019 | - | $11.62B(-38.3%) |
| Dec 2018 | $18.83B(-5.9%) | $18.83B(+9.2%) |
| Sep 2018 | - | $17.24B(+28.4%) |
| Jun 2018 | - | $13.43B(+17.6%) |
| Mar 2018 | - | $11.42B(-42.9%) |
| Dec 2017 | $20.01B(+12.1%) | $20.01B(+18.2%) |
| Sep 2017 | - | $16.93B(+18.1%) |
| Jun 2017 | - | $14.33B(-1.6%) |
| Mar 2017 | - | $14.56B(-18.4%) |
| Dec 2016 | $17.85B(-23.4%) | $17.85B(+24.2%) |
| Sep 2016 | - | $14.37B(-31.4%) |
| Jun 2016 | - | $20.94B(+7.7%) |
| Mar 2016 | - | $19.44B(-16.5%) |
| Dec 2015 | $23.29B(-35.5%) | $23.29B(+12.7%) |
| Sep 2015 | - | $20.66B(-31.7%) |
| Jun 2015 | - | $30.26B(+9.2%) |
| Mar 2015 | - | $27.71B(-23.3%) |
| Dec 2014 | $36.12B(+11.5%) | $36.12B(+8.0%) |
| Sep 2014 | - | $33.45B(-1.8%) |
| Jun 2014 | - | $34.05B(+0.5%) |
| Mar 2014 | - | $33.88B(+4.5%) |
| Dec 2013 | $32.41B(+0.0%) | $32.41B(-3.8%) |
| Sep 2013 | - | $33.68B(-0.1%) |
| Jun 2013 | - | $33.71B(-4.6%) |
| Mar 2013 | - | $35.35B(+8.1%) |
| Dec 2012 | $32.40B(+21.1%) | $32.71B(+42.4%) |
| Sep 2012 | - | $22.97B(-5.5%) |
| Jun 2012 | - | $24.31B(+1.4%) |
| Mar 2012 | - | $23.97B(-10.4%) |
| Dec 2011 | $26.76B(-4.5%) | $26.76B(-7.6%) |
| Sep 2011 | - | $28.96B(+13.7%) |
| Jun 2011 | - | $25.48B(+6.1%) |
| Mar 2011 | - | $24.01B(-14.3%) |
| Dec 2010 | $28.01B(+7.9%) | $28.01B(+24.7%) |
| Sep 2010 | - | $22.46B(+16.6%) |
| Jun 2010 | - | $19.27B(+11.6%) |
| Mar 2010 | - | $17.26B(-33.5%) |
| Dec 2009 | $25.97B(+9.4%) | $25.97B(-50.5%) |
| Sep 2009 | - | $52.47B(+5.7%) |
| Jun 2009 | - | $49.65B(+45.8%) |
| Mar 2009 | - | $34.05B(+43.5%) |
| Dec 2008 | $23.73B | $23.73B(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $26.02B(-0.6%) |
| Jun 2008 | - | $26.18B(-8.6%) |
| Mar 2008 | - | $28.63B(+12.4%) |
| Dec 2007 | $25.48B(-9.7%) | $25.48B(+14.2%) |
| Sep 2007 | - | $22.30B(+0.2%) |
| Jun 2007 | - | $22.25B(-1.0%) |
| Mar 2007 | - | $22.47B(-20.4%) |
| Dec 2006 | $28.23B(+24.2%) | $28.23B(+112.4%) |
| Sep 2006 | - | $13.29B(-12.9%) |
| Jun 2006 | - | $15.26B(-4.3%) |
| Mar 2006 | - | $15.95B(-29.9%) |
| Dec 2005 | $22.74B(+90.2%) | $22.74B(+69.8%) |
| Sep 2005 | - | $13.39B(-8.1%) |
| Jun 2005 | - | $14.57B(-33.7%) |
| Mar 2005 | - | $21.97B(+17.6%) |
| Sep 2004 | - | $18.68B(+56.3%) |
| Dec 2003 | $11.95B(-4.8%) | $11.95B(-4.8%) |
| Dec 2002 | $12.55B(+1111.5%) | $12.55B(+73.7%) |
| Dec 2001 | $1.04B(-5.7%) | - |
| Dec 2000 | $1.10B(-53.4%) | - |
| Sep 2000 | - | $7.22B(+20.6%) |
| Jun 2000 | - | $5.99B(+58.5%) |
| Mar 2000 | - | $3.78B(-23.0%) |
| Dec 1999 | $2.36B(+51.9%) | - |
| Sep 1999 | - | $4.91B(+8.8%) |
| Jun 1999 | - | $4.51B(+7.3%) |
| Mar 1999 | - | $4.21B(+127.5%) |
| Dec 1998 | $1.55B(+77.0%) | - |
| Mar 1998 | - | $1.85B(+110.7%) |
| Dec 1997 | $877.00M(-23.7%) | $877.00M(-26.3%) |
| Sep 1997 | - | $1.19B(-21.4%) |
| Jun 1997 | - | $1.51B(+23.1%) |
| Mar 1997 | - | $1.23B(+7.0%) |
| Dec 1996 | $1.15B(+185.1%) | $1.15B(+9.9%) |
| Sep 1996 | - | $1.05B(+20.2%) |
| Jun 1996 | - | $870.00M(+6.4%) |
| Mar 1996 | - | $818.00M(+102.8%) |
| Dec 1995 | $403.30M(-72.3%) | $403.30M(-45.0%) |
| Sep 1995 | - | $733.60M(+17.6%) |
| Jun 1995 | - | $623.60M(-35.5%) |
| Mar 1995 | - | $967.00M(-33.7%) |
| Dec 1994 | $1.46B(+100.0%) | $1.46B(+63.1%) |
| Sep 1994 | - | $894.20M(+11.2%) |
| Jun 1994 | - | $804.10M(+0.9%) |
| Mar 1994 | - | $796.80M(+9.2%) |
| Dec 1993 | $729.40M(-42.0%) | $729.40M(-40.6%) |
| Sep 1993 | - | $1.23B(+5.9%) |
| Jun 1993 | - | $1.16B(+13.8%) |
| Mar 1993 | - | $1.02B(-18.9%) |
| Dec 1992 | $1.26B(-4.6%) | $1.26B(+16.4%) |
| Sep 1992 | - | $1.08B(+14.6%) |
| Jun 1992 | - | $941.90M(-11.6%) |
| Mar 1992 | - | $1.07B(-19.1%) |
| Dec 1991 | $1.32B(+51.4%) | $1.32B(+95.6%) |
| Sep 1991 | - | $673.50M(-0.3%) |
| Jun 1991 | - | $675.80M(+11.0%) |
| Mar 1991 | - | $608.90M(-30.0%) |
| Dec 1990 | $870.30M(+5.4%) | $870.30M(+182.7%) |
| Sep 1990 | - | $307.90M(-22.9%) |
| Jun 1990 | - | $399.10M(+2.6%) |
| Mar 1990 | - | $388.90M(-52.9%) |
| Dec 1989 | $825.40M(+2.2%) | $825.40M(+2.2%) |
| Dec 1988 | $807.50M(-21.7%) | $807.50M(-21.7%) |
| Dec 1987 | $1.03B(+158.7%) | $1.03B(+158.7%) |
| Dec 1986 | $398.60M(-3.4%) | $398.60M(-3.4%) |
| Dec 1985 | $412.60M(-53.2%) | $412.60M(-53.2%) |
| Dec 1984 | $880.90M | $880.90M |
FAQ
- What is Pfizer Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pfizer Inc.?
- What is Pfizer Inc. annual cash & cash equivalents year-on-year change?
- What is Pfizer Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Pfizer Inc.?
- What is Pfizer Inc. quarterly cash & cash equivalents year-on-year change?
What is Pfizer Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of PFE is $20.48B
What is the all time high annual cash & cash equivalents for Pfizer Inc.?
Pfizer Inc. all-time high annual cash & cash equivalents is $36.12B
What is Pfizer Inc. annual cash & cash equivalents year-on-year change?
Over the past year, PFE annual cash & cash equivalents has changed by +$7.79B (+61.36%)
What is Pfizer Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PFE is $13.25B
What is the all time high quarterly cash & cash equivalents for Pfizer Inc.?
Pfizer Inc. all-time high quarterly cash & cash equivalents is $52.47B
What is Pfizer Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, PFE quarterly cash & cash equivalents has changed by +$6.15B (+86.61%)